Acute eosinophilic pneumonia: Difference between revisions
CSV import |
CSV import |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Acute eosinophilic pneumonia | |||
| synonyms = AEP | |||
| field = [[Pulmonology]] | |||
| symptoms = [[Fever]], [[cough]], [[shortness of breath]], [[chest pain]] | |||
| complications = [[Respiratory failure]] | |||
| onset = Rapid | |||
| duration = Days to weeks | |||
| causes = Often unknown, possible triggers include [[smoking]], [[infections]], [[medications]] | |||
| risks = [[Smoking]], [[male]] gender, [[young adults]] | |||
| diagnosis = [[Chest X-ray]], [[CT scan]], [[bronchoalveolar lavage]], [[lung biopsy]] | |||
| differential = [[Infectious pneumonia]], [[hypersensitivity pneumonitis]], [[chronic eosinophilic pneumonia]] | |||
| treatment = [[Corticosteroids]] | |||
| prognosis = Generally good with treatment | |||
| frequency = Rare | |||
}} | |||
'''Acute Eosinophilic Pneumonia''' ('''AEP''') is a rare and potentially life-threatening condition characterized by the rapid accumulation of eosinophils in the lungs. Eosinophils are a type of white blood cell that play a crucial role in the body's immune response, particularly in fighting off parasitic infections and in allergic reactions. However, their excessive accumulation in the lungs can lead to significant respiratory distress and, if left untreated, may result in acute respiratory failure. | '''Acute Eosinophilic Pneumonia''' ('''AEP''') is a rare and potentially life-threatening condition characterized by the rapid accumulation of eosinophils in the lungs. Eosinophils are a type of white blood cell that play a crucial role in the body's immune response, particularly in fighting off parasitic infections and in allergic reactions. However, their excessive accumulation in the lungs can lead to significant respiratory distress and, if left untreated, may result in acute respiratory failure. | ||
==Etiology== | ==Etiology== | ||
The exact cause of Acute Eosinophilic Pneumonia is not well understood, but it is believed to be associated with an aberrant immune response. Potential triggers include: | The exact cause of Acute Eosinophilic Pneumonia is not well understood, but it is believed to be associated with an aberrant immune response. Potential triggers include: | ||
* [[Inhalation of certain substances]], such as dust, smoke, or chemicals | * [[Inhalation of certain substances]], such as dust, smoke, or chemicals | ||
* [[Medications]], including certain antibiotics, anti-inflammatory drugs, and anticonvulsants | * [[Medications]], including certain antibiotics, anti-inflammatory drugs, and anticonvulsants | ||
* [[Infections]], both parasitic and viral | * [[Infections]], both parasitic and viral | ||
* [[Autoimmune disorders]] | * [[Autoimmune disorders]] | ||
==Symptoms== | ==Symptoms== | ||
Symptoms of AEP can develop rapidly and may include: | Symptoms of AEP can develop rapidly and may include: | ||
* [[Fever]] | * [[Fever]] | ||
* [[Dyspnea]] (difficulty breathing) | * [[Dyspnea]] (difficulty breathing) | ||
| Line 19: | Line 32: | ||
* [[Fatigue]] | * [[Fatigue]] | ||
* [[Weight loss]] | * [[Weight loss]] | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis of Acute Eosinophilic Pneumonia typically involves a combination of clinical evaluation, imaging studies, and laboratory tests, including: | Diagnosis of Acute Eosinophilic Pneumonia typically involves a combination of clinical evaluation, imaging studies, and laboratory tests, including: | ||
* [[Chest X-ray]] and [[CT scan]], which may show infiltrates or other abnormalities in the lungs | * [[Chest X-ray]] and [[CT scan]], which may show infiltrates or other abnormalities in the lungs | ||
* [[Complete blood count]] (CBC), which may reveal elevated eosinophil levels | * [[Complete blood count]] (CBC), which may reveal elevated eosinophil levels | ||
* [[Bronchoalveolar lavage]] (BAL), a procedure that involves washing out the air spaces of the lungs to collect cells and other materials for analysis | * [[Bronchoalveolar lavage]] (BAL), a procedure that involves washing out the air spaces of the lungs to collect cells and other materials for analysis | ||
* [[Lung biopsy]], in rare cases, to obtain a definitive diagnosis | * [[Lung biopsy]], in rare cases, to obtain a definitive diagnosis | ||
==Treatment== | ==Treatment== | ||
Treatment of AEP primarily involves the administration of [[corticosteroids]], which can rapidly reduce inflammation and eosinophil levels in the lungs. In severe cases, additional supportive care may be required, including: | Treatment of AEP primarily involves the administration of [[corticosteroids]], which can rapidly reduce inflammation and eosinophil levels in the lungs. In severe cases, additional supportive care may be required, including: | ||
* [[Oxygen therapy]] to maintain adequate blood oxygen levels | * [[Oxygen therapy]] to maintain adequate blood oxygen levels | ||
* [[Mechanical ventilation]] in cases of respiratory failure | * [[Mechanical ventilation]] in cases of respiratory failure | ||
* Treatment of any underlying causes or associated conditions | * Treatment of any underlying causes or associated conditions | ||
==Prognosis== | ==Prognosis== | ||
With prompt and appropriate treatment, the prognosis for individuals with Acute Eosinophilic Pneumonia is generally good, and most patients experience a full recovery. However, relapses can occur, particularly if the underlying cause is not identified and addressed. | With prompt and appropriate treatment, the prognosis for individuals with Acute Eosinophilic Pneumonia is generally good, and most patients experience a full recovery. However, relapses can occur, particularly if the underlying cause is not identified and addressed. | ||
==Prevention== | ==Prevention== | ||
Prevention of AEP involves avoiding known triggers, such as smoking or exposure to certain chemicals or drugs. Individuals with a history of AEP or other eosinophilic disorders should inform their healthcare providers of their condition when being prescribed new medications or when exposed to potential environmental triggers. | Prevention of AEP involves avoiding known triggers, such as smoking or exposure to certain chemicals or drugs. Individuals with a history of AEP or other eosinophilic disorders should inform their healthcare providers of their condition when being prescribed new medications or when exposed to potential environmental triggers. | ||
[[Category:Respiratory diseases]] | [[Category:Respiratory diseases]] | ||
[[Category:Immune system disorders]] | [[Category:Immune system disorders]] | ||
[[Category:Lung disorders]] | [[Category:Lung disorders]] | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
Latest revision as of 22:18, 3 April 2025
| Acute eosinophilic pneumonia | |
|---|---|
| Synonyms | AEP |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Fever, cough, shortness of breath, chest pain |
| Complications | Respiratory failure |
| Onset | Rapid |
| Duration | Days to weeks |
| Types | N/A |
| Causes | Often unknown, possible triggers include smoking, infections, medications |
| Risks | Smoking, male gender, young adults |
| Diagnosis | Chest X-ray, CT scan, bronchoalveolar lavage, lung biopsy |
| Differential diagnosis | Infectious pneumonia, hypersensitivity pneumonitis, chronic eosinophilic pneumonia |
| Prevention | N/A |
| Treatment | Corticosteroids |
| Medication | N/A |
| Prognosis | Generally good with treatment |
| Frequency | Rare |
| Deaths | N/A |
Acute Eosinophilic Pneumonia (AEP) is a rare and potentially life-threatening condition characterized by the rapid accumulation of eosinophils in the lungs. Eosinophils are a type of white blood cell that play a crucial role in the body's immune response, particularly in fighting off parasitic infections and in allergic reactions. However, their excessive accumulation in the lungs can lead to significant respiratory distress and, if left untreated, may result in acute respiratory failure.
Etiology[edit]
The exact cause of Acute Eosinophilic Pneumonia is not well understood, but it is believed to be associated with an aberrant immune response. Potential triggers include:
- Inhalation of certain substances, such as dust, smoke, or chemicals
- Medications, including certain antibiotics, anti-inflammatory drugs, and anticonvulsants
- Infections, both parasitic and viral
- Autoimmune disorders
Symptoms[edit]
Symptoms of AEP can develop rapidly and may include:
- Fever
- Dyspnea (difficulty breathing)
- Cough, which may be dry or productive
- Hypoxemia (low blood oxygen levels)
- Chest pain
- Fatigue
- Weight loss
Diagnosis[edit]
Diagnosis of Acute Eosinophilic Pneumonia typically involves a combination of clinical evaluation, imaging studies, and laboratory tests, including:
- Chest X-ray and CT scan, which may show infiltrates or other abnormalities in the lungs
- Complete blood count (CBC), which may reveal elevated eosinophil levels
- Bronchoalveolar lavage (BAL), a procedure that involves washing out the air spaces of the lungs to collect cells and other materials for analysis
- Lung biopsy, in rare cases, to obtain a definitive diagnosis
Treatment[edit]
Treatment of AEP primarily involves the administration of corticosteroids, which can rapidly reduce inflammation and eosinophil levels in the lungs. In severe cases, additional supportive care may be required, including:
- Oxygen therapy to maintain adequate blood oxygen levels
- Mechanical ventilation in cases of respiratory failure
- Treatment of any underlying causes or associated conditions
Prognosis[edit]
With prompt and appropriate treatment, the prognosis for individuals with Acute Eosinophilic Pneumonia is generally good, and most patients experience a full recovery. However, relapses can occur, particularly if the underlying cause is not identified and addressed.
Prevention[edit]
Prevention of AEP involves avoiding known triggers, such as smoking or exposure to certain chemicals or drugs. Individuals with a history of AEP or other eosinophilic disorders should inform their healthcare providers of their condition when being prescribed new medications or when exposed to potential environmental triggers.
